首页> 外国专利> System and method of modeling erythropoiesis and its management

System and method of modeling erythropoiesis and its management

机译:红细胞生成及其管理的系统和方法

摘要

A method of adjusting a patient's undesired hematocrit and/or hemoglobin concentration to a value within a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen includes obtaining patient parameters required for input into a model for predicting the patient's hematocrit and/or hemoglobin concentration at a predetermined time with a selected ESA administration regimen, and employing the patient parameters and an initially selected EPO administration regimen in the model to predict the patient's hematocrit and/or hemoglobin concentration at the predetermined time with the initially selected ESA administration regimen. Optionally, if the patient's hematocrit and/or hemoglobin concentration is not predicted by the model to be in the desired range at the predetermined time, the method includes employing the model with one or more different ESA administration regimens until the model predicts that the patient's hematocrit and/or hemoglobin concentration will be in the desired range at the predetermined time. The method then includes administering ESA to the patient with an ESA administration regimen predicted to adjust the patient's hematocrit and/or hemoglobin concentration to the desired range at the predetermined time. The method can be implemented in a computer system for adjusting a patient's undesired hematocrit and/or hemoglobin concentration to a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen.
机译:一种通过促红细胞生成刺激剂(ESA)方案在预定时间将患者不需要的血细胞比容和/或血红蛋白浓度调节至所需范围内的值的方法,该方法包括获取输入模型所需的患者参数,以预测患者的血细胞比容和/或选定的ESA给药方案在预定时间的血红蛋白浓度或血红蛋白浓度,并在模型中采用患者参数和最初选择的EPO给药方案,以最初选择的ESA给药方案在预定时间预测患者的血细胞比容和/或血红蛋白浓度。可选地,如果模型在预定时间未将患者的血细胞比容和/或血红蛋白浓度预测在所需范围内,则该方法包括将模型与一种或多种不同的ESA给药方案一起使用,直到模型预测患者的血细胞比容和/或血红蛋白浓度将在预定时间处于期望的范围内。然后,该方法包括通过预测在预定时间将患者的血细胞比容和/或血红蛋白浓度调节至所需范围的ESA施用方案,向患者施用ESA。该方法可以在计算机系统中实现,该计算机系统使用促红细胞生成剂(ESA)方案在预定时间将患者不需要的血细胞比容和/或血红蛋白浓度调节到所需范围。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号